Drug intelligence / Profile preview

manzamine a

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Manzamine A is a marine-derived, β-carboline-fused pentacyclic alkaloid found in several marine sponge genera, including Haliclona and Acanthostrongylophora. It demonstrates diverse biological activities, including anticancer, antimalarial, antiviral (notably against HSV-1 and HIV-1), anti-hyperlipidemic, anti-atherosclerotic, antimicrobial, and potential neuroprotective effects. Mechanistically, Manzamine A is known to inhibit Glycogen Synthase Kinase-3 (GSK-3), modulate SIX1 gene expression, disrupt autophagy by uncoupling vacuolar ATPases, and inhibit other proteins involved in cellular proliferation (e.g., JAK2, AKT, PKC, FAK, Bcl-2, IκB). It causes cell cycle arrest, suppresses the epithelial–mesenchymal transition, and can induce apoptosis in various cancer cell types. It is being actively investigated in preclinical and early-phase research for multiple therapeutic areas including cancer, Alzheimer’s disease, and infectious diseases[1][2][3][5][7][9].

Other names
Manzamine AKeramamine A104196-68-1CHEBI:66667
02

Targets

CK2 (Casein kinase II subunit alpha)JAK2 (Janus kinase 2)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IKBKB (IKKβ)GSK3 (Glycogen synthase kinase 3 beta)PKC (Protein kinase C family)FAK (Focal adhesion kinase)

Beyond the preview

Go deeper on manzamine a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on manzamine a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call